Comparative Pharmacology
Head-to-head clinical analysis: MULTIHANCE MULTIPACK versus TESLASCAN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MULTIHANCE MULTIPACK versus TESLASCAN.
MULTIHANCE MULTIPACK vs TESLASCAN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Gadobenate dimeglumine is a paramagnetic contrast agent that enhances magnetic resonance imaging by increasing the relaxation rate of water protons in tissues where it accumulates. The gadolinium ion (Gd3+) shortens T1 and T2 relaxation times, leading to increased signal intensity on T1-weighted images.
Teslascan is a manganese-based paramagnetic contrast agent that enhances T1-weighted magnetic resonance imaging (MRI). Manganese ions shorten the T1 relaxation time of protons, increasing signal intensity in tissues where it accumulates.
0.1 mmol/kg body weight (0.2 mL/kg) intravenous bolus injection; maximum single dose 0.3 mmol/kg (0.6 mL/kg)
0.1 mL/kg (0.1 mmol/kg) intravenous bolus injection.
None Documented
None Documented
Terminal elimination half-life: 1.5–2.2 hours in patients with normal renal function; prolonged (up to 30 hours) in severe renal impairment (eGFR <30 mL/min/1.73m²)
Terminal elimination half-life is 6.2 hours in patients with normal renal function (CrCl > 60 mL/min). In patients with moderate renal impairment (CrCl 30-60 mL/min), half-life increases to 9.5 hours; in severe impairment (CrCl < 30 mL/min), half-life exceeds 15 hours.
Renal excretion: 95% unchanged drug via glomerular filtration; biliary/fecal: <0.1%
70% renal (unchanged drug), 30% fecal (biliary excretion).
Category C
Category C
MRI Contrast Agent
MRI Contrast Agent